BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND HSP90AB1, HSPCB, 3326, ENSG00000096384, HSP90B, HSP90-BETA, P08238, D6S182, HSPC2, FLJ26984 AND Treatment
5 results:

  • 1. Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma.
    Thompson JC; Davis C; Deshpande C; Hwang WT; Jeffries S; Huang A; Mitchell TC; Langer CJ; Albelda SM
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33028693
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification of a gene signature for discriminating metastatic from primary melanoma using a molecular interaction network approach.
    Metri R; Mohan A; Nsengimana J; Pozniak J; Molina-Paris C; Newton-Bishop J; Bishop D; Chandra N
    Sci Rep; 2017 Dec; 7(1):17314. PubMed ID: 29229936
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Potential diagnostic significance of HSP90, ACS/TMS1, and L-plastin in the identification of melanoma.
    Strickler AG; Vasquez JG; Yates N; Ho J
    Melanoma Res; 2014 Dec; 24(6):535-44. PubMed ID: 25191796
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Achievement of long-term local control in patients with craniopharyngiomas using high precision stereotactic radiotherapy.
    Combs SE; Thilmann C; Huber PE; Hoess A; Debus J; Schulz-Ertner D
    Cancer; 2007 Jun; 109(11):2308-14. PubMed ID: 17469176
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Fractionated ionizing radiation exposure induces apoptosis through caspase-3 activation and reactive oxygen species generation.
    Bucci B; Misiti S; Cannizzaro A; Marchese R; Raza GH; Miceli R; Stigliano A; Amendola D; Monti O; Biancolella M; Amati F; Novelli G; Vecchione A; Brunetti E; De Paula U
    Anticancer Res; 2006; 26(6B):4549-57. PubMed ID: 17201177
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.